AbbVie, Inc.
(NYSE : ABBV)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson
0.52%142.380.6%$784.32m
MRKMerck & Co., Inc.
0.38%56.220.6%$704.80m
PFEPfizer Inc.
2.00%37.190.8%$585.67m
ABBVAbbVie, Inc.
1.16%97.422.1%$456.67m
LLYEli Lilly and Company
0.07%86.561.0%$305.25m
BMYBristol-Myers Squibb Company
0.42%62.391.4%$301.27m
GSKGlaxoSmithKline plc Sponsored ADR
-0.74%34.980.2%$174.16m
NVSNovartis AG Sponsored ADR
0.47%84.870.2%$106.77m
AZNAstraZeneca PLC Sponsored ADR
-0.48%33.131.3%$91.12m
NVONovo Nordisk A/S Sponsored ADR Class B
-0.66%52.510.1%$66.72m
SNYSanofi Sponsored ADR
0.05%43.110.2%$51.33m
SCMPSucampo Pharmaceuticals, Inc. Class A
1.49%17.0014.4%$40.06m
LCILannett Company, Inc.
-1.96%27.5538.2%$22.97m
AKTXAkari Therapeutics Plc Sponsored ADR
0.97%4.172.2%$1.56m
EPIXESSA Pharma Inc
-4.55%0.210.0%$0.02m

Company Profile

AbbVie, Inc. is a research-based biopharmaceutical company. It engages in the discovery, development, manufacture and sale of a broad line of proprietary pharmaceutical products. The company focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C and human immunodeficiency virus; neurological disorders, such as Parkinson's disease; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; as well as other serious health conditions. The company was founded on January 1, 2013 and is headquartered in North Chicago, IL.